Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) has a beta value of 1.82 and has seen 5,382,811 shares traded in the recent trading session. The company, currently valued at $140.83 Million, closed the recent trade at $1.11 per share which meant it lost -$0.05 on the day or -4.3% during that session. The TNXP stock price is -431.53% off its 52-week high price of $5.9 and 64.86% above the 52-week low of $0.39. If we look at the company’s 10-day average daily trading volume, we find that it stood at 15.22 Million shares traded. The 3-month trading volume is 24.6 Million shares.

The consensus among analysts is that Tonix Pharmaceuticals Holding Corp. (TNXP) is a Buy stock at the moment, with a recommendation rating of 2. None of the analysts rate the stock as a Sell, while none rate it as Overweight. None out of 1 have rated it as a Hold, with 1 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.22.

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) trade information

Despite being -4.3% in the red today, the stock has traded in the green over the last five days, with the highest price hit on Thursday, Aug 06 when the TNXP stock price touched $1.37 or saw a rise of 18.61%. Year-to-date, Tonix Pharmaceuticals Holding Corp. shares have moved -4.7%, while the 5-day performance has seen it change -10.08%. Over the past 30 days, the shares of Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) have changed 73.81%. Short interest in the company has seen 1.44 Million shares shorted with days to cover at 0.06.

Wall Street analysts have a consensus price target for the stock at $2.5, which means that the shares’ value could jump 125.23% from current levels. The projected low price target is $2.5 while the price target rests at a high of $2.5. In that case, then, we find that the current price level is +125.23% off the targeted high while a plunge would see the stock lose 125.23% from current levels.

Tonix Pharmaceuticals Holding Corp. (TNXP) estimates and forecasts

Earnings growth for 2020 is a modest +92.8%.